Screening For BCRL In Targeted Therapy For Breast Cancer
NCT: NCT05142800 · RECRUITING
NCT IDNCT05142800
StatusRECRUITING
Start Date2018-12-13
Completion2026-09-30
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated
Brief Summary
This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer. A Perometer and Sozo devise will be used to measure volume changes
Frequently Asked Questions
What is Screening For BCRL In Targeted Therapy For Breast Cancer?
Screening For BCRL In Targeted Therapy For Breast Cancer is a clinical trial registered under NCT05142800. Current status: RECRUITING.
What is the status of NCT05142800?
The current status of NCT05142800 (Screening For BCRL In Targeted Therapy For Breast Cancer) is: RECRUITING.
When did Screening For BCRL In Targeted Therapy For Breast Cancer start?
Screening For BCRL In Targeted Therapy For Breast Cancer started on 2018-12-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.